{"id":"https://openalex.org/W4396996462","doi":"https://doi.org/10.1681/asn.20203110s1b9c","title":"Phase 2 Study of N-Acetylmannosamine (ManNAc) for Glomerular Diseases","display_name":"Phase 2 Study of N-Acetylmannosamine (ManNAc) for Glomerular Diseases","publication_year":2020,"publication_date":"2020-10-01","ids":{"openalex":"https://openalex.org/W4396996462","doi":"https://doi.org/10.1681/asn.20203110s1b9c"},"language":"en","primary_location":{"id":"doi:10.1681/asn.20203110s1b9c","doi":"https://doi.org/10.1681/asn.20203110s1b9c","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1681/asn.20203110s1b9c","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086550680","display_name":"Marjan Huizing","orcid":"https://orcid.org/0000-0002-9375-9539","observed_orcids":["https://orcid.org/0000-0002-9375-9539"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210090236","display_name":"National Human Genome Research Institute","ror":"https://ror.org/00baak391","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210090236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marjan Huizing","raw_affiliation_strings":["Medical Genetics Branch, NHGRI, NIH, Bethesda, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Genetics Branch, NHGRI, NIH, Bethesda, MD;","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210090236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013289245","display_name":"J. Thomas Blake","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210090567","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210090567"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jodi Blake","raw_affiliation_strings":["Kidney Disease Section, NIDDK, NIH, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kidney Disease Section, NIDDK, NIH, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210090567"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082442398","display_name":"William Allen Gahl","orcid":"https://orcid.org/0000-0002-2494-6752","observed_orcids":["https://orcid.org/0000-0002-2494-6752"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210090236","display_name":"National Human Genome Research Institute","ror":"https://ror.org/00baak391","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210090236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William Gahl","raw_affiliation_strings":["Medical Genetics Branch, NHGRI, NIH, Bethesda, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Genetics Branch, NHGRI, NIH, Bethesda, MD;","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210090236"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044494633","display_name":"Jeffrey B. Kopp","orcid":"https://orcid.org/0000-0001-9052-186X","observed_orcids":["https://orcid.org/0000-0001-9052-186X"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210090567","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210090567"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey B. Kopp","raw_affiliation_strings":["Kidney Disease Section, NIDDK, NIH, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kidney Disease Section, NIDDK, NIH, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210090567"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"10S","first_page":"B9","last_page":"B9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10602","display_name":"Glycosylation and Glycoproteins Research","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/n-acetylmannosamine","display_name":"N-acetylmannosamine","score":0.9309999942779541},{"id":"https://openalex.org/keywords/sialic-acid","display_name":"sialic acid","score":0.8180000185966492},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.6669999957084656},{"id":"https://openalex.org/keywords/focal-segmental-glomerulosclerosis","display_name":"focal segmental glomerulosclerosis","score":0.9459999799728394},{"id":"https://openalex.org/keywords/minimal-change-disease","display_name":"minimal change disease","score":0.9959999918937683},{"id":"https://openalex.org/keywords/membranous-nephropathy","display_name":"membranous nephropathy","score":1.0},{"id":"https://openalex.org/keywords/nephrotic-syndrome","display_name":"nephrotic syndrome","score":0.9110000133514404},{"id":"https://openalex.org/keywords/podocyte-dysfunction","display_name":"podocyte dysfunction","score":0.7310000061988831},{"id":"https://openalex.org/keywords/oral-drug-therapy","display_name":"oral drug therapy","score":0.45500001311302185},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.8059999942779541},{"id":"https://openalex.org/keywords/gne-myopathy","display_name":"GNE myopathy","score":0.8149999976158142},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7400000095367432},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.628000020980835}],"concepts":[{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.47789013385772705},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4714202284812927},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43108734488487244},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3387134075164795},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1681/asn.20203110s1b9c","doi":"https://doi.org/10.1681/asn.20203110s1b9c","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1681/asn.20203110s1b9c","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4396998400","https://openalex.org/W2955634686","https://openalex.org/W7117648071","https://openalex.org/W4416066949","https://openalex.org/W1988893071","https://openalex.org/W2498934859","https://openalex.org/W2162498914","https://openalex.org/W2042724854","https://openalex.org/W1539643750","https://openalex.org/W2397267740"],"abstract_inverted_index":{"Background:":[0],"Sialic":[1],"acid":[2,108,142],"residues":[3],"provide":[4],"anionic":[5],"charges":[6],"to":[7,30,62,121,161,290],"proteins,":[8],"including":[9,329],"those":[10],"of":[11,18,47,91,166,181,218,242,252,259,292,303,331,337],"the":[12,64,164,240,243,304,335],"glomerular":[13,22,51,78,167,208,275,320,332],"filtration":[14],"barrier.":[15],"Lectin":[16],"analysis":[17,217,336],"kidney":[19],"biopsies":[20],"showed":[21,36,97,150],"hyposialylation":[23,66],"in":[24,37,93,128,154,265,334],"nephrotic":[25,38,95],"diseases,":[26],"this":[27],"may":[28,324],"contribute":[29],"podocyte":[31],"dysfunction":[32],"and":[33,53,103,119,185,207,238,250,263,294,317],"proteinuria.":[34,56],"We":[35,187],"mouse":[39],"models":[40],"that":[41,98],"oral":[42,99,225],"ManNAc,":[43],"an":[44],"uncharged":[45],"precursor":[46],"sialic":[48,107,141],"acid,":[49],"normalized":[50],"sialylation":[52,211,333],"markedly":[54],"decreased":[55],"ManNAc":[57,92,100,113,147,226,269,277],"is":[58,281,284],"also":[59],"being":[60],"studied":[61],"treat":[63],"rare":[65],"disorder":[67],"GNE":[68],"myopathy":[69],"(NCT04231266);":[70],"it":[71],"could":[72,295],"be":[73,213],"repurposed":[74],"for":[75,229,315],"patients":[76],"with":[77,130,137,163,192,232,274],"hyposialylation.":[79,168,209,276],"Methods:":[80],"Phase":[81,170],"1":[82,86],"Results:":[83,169],"A":[84],"phase":[85,175,306],"study":[87,177],"(NCT02639260;":[88],"IND":[89],"125,192)":[90],"7":[94],"subjects":[96,129,145,273],"was":[101],"safe":[102],"well-tolerated.":[104],"Plasma":[105],"free":[106,140],"levels":[109],"peaked":[110],"\u02dc10h":[111],"after":[112],"dosing,":[114,126],"remained":[115],"elevated":[116],"beyond":[117],"48h,":[118],"continued":[120],"increase":[122],"during":[123],"twice":[124,148,227],"daily":[125,149,228],"particularly":[127],"low":[131],"eGFR.":[132,266],"No":[133],"adverse":[134],"events":[135],"occurred":[136],"increased":[138],"plasma":[139],"levels.":[143],"Most":[144],"receiving":[146],"a":[151,288,311],"26-54%":[152],"reduction":[153,251,291],"urine":[155],"protein/creatinine":[156],"ratio":[157],"(UPCR),":[158],"which":[159],"appeared":[160],"correlate":[162],"degree":[165],"2":[171,176,307],"Design:":[172],"An":[173],"open-label":[174],"will":[178,188,212,223,247,256],"include":[179,248,257],"assessment":[180,330],"longer-term":[182],"pharmacokinetics,":[183],"safety":[184,249],"efficacy.":[186],"enroll":[189],"12":[190,230],"adults":[191],"focal":[193],"segmental":[194],"glomerulosclerosis,":[195],"minimal":[196,279],"change":[197,325],"disease":[198],"or":[199,297],"membranous":[200],"nephropathy,":[201],"UPCR":[202],">2g/g,":[203],"eGFR":[204],">45":[205],"ml/min/1.73m2":[206],"Glomerular":[210],"assessed":[214],"by":[215,328],"lectin":[216],"previous":[219],"diagnostic":[220],"biopsies.":[221,339],"Subjects":[222],"receive":[224],"weeks,":[231],"clinical":[233],"evaluations":[234],"at":[235,239],"baseline,":[236],"interim":[237],"end":[241],"study.":[244],"Study":[245],"outcomes":[246,255,262],"UPCR.":[253],"Exploratory":[254],"quality":[258],"life,":[260],"patient-reported":[261],"improvement":[264],"Conclusions:":[267],"Oral":[268],"therapy":[270],"might":[271,309],"benefit":[272],"has":[278],"toxicity,":[280],"well":[282],"tolerated,":[283],"easily":[285],"administered,":[286],"shows":[287],"trend":[289],"proteinuria,":[293],"replace":[296],"augment":[298],"existing":[299],"therapies.":[300],"The":[301],"results":[302,323],"planned":[305],"trial":[308],"offer":[310],"new":[312],"therapeutic":[313],"approach":[314],"primary":[316],"perhaps":[318],"secondary":[319],"diseases.":[321],"Such":[322],"medical":[326],"practice":[327],"renal":[338],"Funding:":[340],"NIDDK":[341],"Support,":[342],"Other":[343],"NIH":[344],"Support":[345,348],"-":[346],"NHGRI":[347]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2024-05-18T00:00:00"}